WitrynaThe IMS PharMetrics Plus database also contains data from Medicare supplemental plans covering patients above the age of 65, an important segment of the study population as advanced age is a risk factor for the development of VTE. Study Population Claims data from January 1, 2008, to March 31, 2014, were WitrynaThis retrospective database analysis utilized IMS LifeLink PharMetrics Plus™ commercial claims, which consists of adjudicated claims of more than 150 million unique enrollees across the US since 2006, including more than 95 million individuals with both medical and pharmacy benefits.
Available IQVIA Data - IQVIA
Witryna31 maj 2016 · The IMS PharMetrics Plus database contains data on fully adjudicated medical and pharmaceutical claims for over 150 million unique enrollees across the US. It includes information on diagnosis, procedures, prescriptions and inpatient treatment. The database covers 90% of US hospitals, 80% of US doctors, and 85% of large (Fortune … WitrynaThe IMS PharMetrics Plus database is composed of adjudicated claims for more than 150 million unique insured (both commercial and Medicare) enrollees across the US. Enrollees with both medical and pharmacy coverage in … the pickaquoy centre
Quantification of missing prescriptions in commercial claims databases ...
Witryna2 lip 2024 · To identify potential changes to prescribing patterns and the extent of tamsulosin use for conditions beyond its original indication, we evaluated tamsulosin … Witryna28 kwi 2024 · Similarly, out of 35,083,356 adult patients in the IMS PharMetrics Plus database, 139,300 (0.50%) patients met our criteria for RA. In 2014, the overall age … Witryna6 sty 2024 · Data are from the IMS Health PharMetrics Plus Database, which contains individual-level, de-identified health care claims information from employers, hospitals, and health plans on more than 150 million commercially insured patients in the United States. Data were extracted for medical claims for VWD (ICD-9 286.4), other bleeding … sickness 中文